RCERecce PharmaceuticalsRCE info
$0.35info0.00%24h
Global rank23181
Market cap$61.22M
Change 7d-6.36%
YTD Performance-2.83%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings-$8.85M
Dividend yield-
Main Sector
Healthcare

Recce Pharmaceuticals (RCE) Total Liabilities

RCE Total Liabilities in 2022: $3.48M

According to Recce Pharmaceuticals latest financial reports the total liabilities of RCE is $3.48M, an increase of 100.79% to 2022. At the end of 2022 company had $1.73M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Recce Pharmaceuticals is responsible for during its operational activities.

Recce Pharmaceuticals (RCE) Total Liabilities History from 2023 to 2022

-
Value:-

RCE Total Liabilities by year

YearTotal liabilitiesChange
2023$3.48M100.79%
2022$1.73M117.54%
2021$796.83K26.44%
2020$630.21K8.09%
2019$583.05K-

View the Top Total Liabilies Stocks

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org